Dark

TNXP
Tonix Pharmaceuticals Holding Corp.
stock NASDAQ

At Close

Aug 29, 2025 3:59:50 PM EDT

29.59USD-3.960%(-1.22)674,415

0.00Bid 0.00Ask 0.00Spread

Pre-market

Aug 29, 2025 9:28:30 AM EDT

30.67USD-0.454%(-0.14)5,557

After-hours

Aug 29, 2025 4:47:30 PM EDT

29.51USD-0.270%(-0.08)2,546

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

259.30M

CEO

Seth Lederman

Headquarters

New York, USA

Industry

Biotechnology

Next Earnings

Nov 10, 2025 (72d)

Last Split

Feb 5, 20251for100reverse

ARQL SUPN PRGO AGRX XLV

TNXP Stats

Avg. Vol. 10 Day

1,987,227

Avg. Vol. 30 Day

1,894,114

Employees

Market Cap

259,295,204

Shares Out.

8,765,896

On/Off Exchange

39%/61%

6 Month Beta

0.82

1 Year Beta

1.16

2 Year Beta

1.03

3 Year Beta

1.08

52 Week Low

6.76

52 Week High

130.00

SMA50

41.19

SMA200

27.74

1 Week

-22.12%

1 Month

-23.41%

3 Month

-25.64%

6 Month

+300.81%

1 Year

+29.17%

2 Year

-99.02%

5 Year

-100.00%

Profile

tonix is developing innovative pharmaceutical products to address major public health challenges. in addition to tonmya for ptsd, tonix is developing tnx-601 (tianeptine oxalate), a clinical candidate at pre-ind (investigational new drug) application stage, designed as a daytime treatment for ptsd and tnx-801, a live synthetic version of horsepox virus, at the pre-ind application stage, to be developed as a potential smallpox-preventing vaccine. further information about tonix can be found at www.tonixpharma.com.

TNXP Stock Summary

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) stock price today is $29.59, and today's volume is 674,415. TNXP is down -3.960% today. The 30 day average volume is 1,894,114. TNXP market cap is 259.30M with 8,765,896 shares outstanding.